Reaction

Pigment Dispersion Syndrome reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 92 reports · 1 co-occurring drugs

As of the last recalculation, Pigment Dispersion Syndrome appears in 92 FAERS reports alongside 1 co-occurring drug terms. The strongest observed disproportionality signal is MOXIFLOXACIN (PRR 221.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Moxifloxacin12221.5221.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.